Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1522079

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1522079

LAMEA Precision Diagnostics Market Size, Share & Trends Analysis Report By End-use, By Type, By Application, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 147 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Precision Diagnostics Market would witness market growth of 20.9% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Precision Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,016.1 million by 2031. The Argentina market is registering a CAGR of 21.6% during (2024 - 2031). Additionally, The UAE market would showcase a CAGR of 19.8% during (2024 - 2031).

Precision diagnostics aid in diagnosing, monitoring, and personalized managing autoimmune diseases and immune deficiencies. They detect specific autoantibodies (such as ANA and anti-dsDNA) to diagnose conditions like lupus and rheumatoid arthritis.

Additionally, they analyze immune cell subsets, cytokines, and inflammatory markers to characterize immune responses and assess disease activity. Multiplex assays for profiling immune biomarkers in autoimmune diseases and predicting treatment responses.

The prevalence of non-communicable diseases such as cardiovascular diseases, diabetes, cancer, and respiratory disorders is rising in Saudi Arabia. This demographic shift towards chronic conditions necessitates accurate and early diagnosis to effectively manage these diseases. According to the International Trade Administration (ITA), non-communicable diseases account for 68 percent of all deaths in Saudi Arabia. Almost 18 percent of the adult population has diabetes, and more than 40 percent are obese.

Based on End-use, the market is segmented into Clinical Laboratories, Hospitals, and Others. Based on Type, the market is segmented into Genetic Tests, Esoteric Tests, Direct to Consumer Tests, and Others. Based on Application, the market is segmented into Oncology, Respiratory Diseases, CNS Disorders, Immunology, Skin Diseases, Genetic Diseases, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG (Siemens AG)
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • BioMerieux S.A.
  • Becton, Dickinson and Company
  • Qiagen N.V
  • Hologic, Inc.

LAMEA Precision Diagnostics Market Report Segmentation

By End-use

  • Clinical Laboratories
  • Hospitals
  • Others

By Type

  • Genetic Tests
  • Esoteric Tests
  • Direct to Consumer Tests
  • Others

By Application

  • Oncology
  • Respiratory Diseases
  • CNS Disorders
  • Immunology
  • Skin Diseases
  • Genetic Diseases
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Precision Diagnostics Market, by End-use
    • 1.4.2 LAMEA Precision Diagnostics Market, by Type
    • 1.4.3 LAMEA Precision Diagnostics Market, by Application
    • 1.4.4 LAMEA Precision Diagnostics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
  • 4.3 Top Winning Strategies
    • 4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
    • 4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jul - 2024, May) Leading Players
  • 4.4 Porter Five Forces Analysis

Chapter 5. LAMEA Precision Diagnostics Market by End-use

  • 5.1 LAMEA Clinical Laboratories Market by Country
  • 5.2 LAMEA Hospitals Market by Country
  • 5.3 LAMEA Others Market by Country

Chapter 6. LAMEA Precision Diagnostics Market by Type

  • 6.1 LAMEA Genetic Tests Market by Country
  • 6.2 LAMEA Esoteric Tests Market by Country
  • 6.3 LAMEA Direct to Consumer Tests Market by Country
  • 6.4 LAMEA Others Market by Country

Chapter 7. LAMEA Precision Diagnostics Market by Application

  • 7.1 LAMEA Oncology Market by Country
  • 7.2 LAMEA Respiratory Diseases Market by Country
  • 7.3 LAMEA CNS Disorders Market by Country
  • 7.4 LAMEA Immunology Market by Country
  • 7.5 LAMEA Skin Diseases Market by Country
  • 7.6 LAMEA Genetic Diseases Market by Country
  • 7.7 LAMEA Others Market by Country

Chapter 8. LAMEA Precision Diagnostics Market by Country

  • 8.1 Brazil Precision Diagnostics Market
    • 8.1.1 Brazil Precision Diagnostics Market by End-use
    • 8.1.2 Brazil Precision Diagnostics Market by Type
    • 8.1.3 Brazil Precision Diagnostics Market by Application
  • 8.2 Argentina Precision Diagnostics Market
    • 8.2.1 Argentina Precision Diagnostics Market by End-use
    • 8.2.2 Argentina Precision Diagnostics Market by Type
    • 8.2.3 Argentina Precision Diagnostics Market by Application
  • 8.3 UAE Precision Diagnostics Market
    • 8.3.1 UAE Precision Diagnostics Market by End-use
    • 8.3.2 UAE Precision Diagnostics Market by Type
    • 8.3.3 UAE Precision Diagnostics Market by Application
  • 8.4 Saudi Arabia Precision Diagnostics Market
    • 8.4.1 Saudi Arabia Precision Diagnostics Market by End-use
    • 8.4.2 Saudi Arabia Precision Diagnostics Market by Type
    • 8.4.3 Saudi Arabia Precision Diagnostics Market by Application
  • 8.5 South Africa Precision Diagnostics Market
    • 8.5.1 South Africa Precision Diagnostics Market by End-use
    • 8.5.2 South Africa Precision Diagnostics Market by Type
    • 8.5.3 South Africa Precision Diagnostics Market by Application
  • 8.6 Nigeria Precision Diagnostics Market
    • 8.6.1 Nigeria Precision Diagnostics Market by End-use
    • 8.6.2 Nigeria Precision Diagnostics Market by Type
    • 8.6.3 Nigeria Precision Diagnostics Market by Application
  • 8.7 Rest of LAMEA Precision Diagnostics Market
    • 8.7.1 Rest of LAMEA Precision Diagnostics Market by End-use
    • 8.7.2 Rest of LAMEA Precision Diagnostics Market by Type
    • 8.7.3 Rest of LAMEA Precision Diagnostics Market by Application

Chapter 9. Company Profiles

  • 9.1 Abbott Laboratories
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Acquisition and Mergers:
    • 9.1.6 SWOT Analysis
  • 9.2 F. Hoffmann-La Roche Ltd.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Partnerships, Collaborations, and Agreements:
      • 9.2.5.2 Product Launches and Product Expansions:
    • 9.2.6 SWOT Analysis
  • 9.3 Siemens Healthineers AG (Siemens AG)
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Partnerships, Collaborations, and Agreements:
      • 9.3.5.2 Product Launches and Product Expansions:
      • 9.3.5.3 Acquisition and Mergers:
    • 9.3.6 SWOT Analysis
  • 9.4 Thermo Fisher Scientific, Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expenses
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Partnerships, Collaborations, and Agreements:
    • 9.4.6 SWOT Analysis
  • 9.5 Danaher Corporation
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 Recent strategies and developments:
    • 9.5.6 SWOT Analysis
  • 9.6 Agilent Technologies, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segmental and Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Partnerships, Collaborations, and Agreements:
      • 9.6.5.2 Product Launches and Product Expansions:
    • 9.6.6 SWOT Analysis
  • 9.7 BioMerieux S.A.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 Recent strategies and developments:
      • 9.7.5.1 Partnerships, Collaborations, and Agreements:
      • 9.7.5.2 Acquisition and Mergers:
    • 9.7.6 SWOT Analysis
  • 9.8 Becton, Dickinson, and Company
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expense
    • 9.8.5 SWOT Analysis
  • 9.9 Qiagen N.V.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Regional Analysis
    • 9.9.4 Research & Development Expenses
    • 9.9.5 Recent strategies and developments:
      • 9.9.5.1 Partnerships, Collaborations, and Agreements:
      • 9.9.5.2 Product Launches and Product Expansions:
    • 9.9.6 SWOT Analysis
  • 9.10. Hologic, Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Segmental and Regional Analysis
    • 9.10.4 Research & Development Expenses
    • 9.10.5 SWOT Analysis

LIST OF TABLES

  • TABLE 1 LAMEA Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 2 LAMEA Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements - Precision Diagnostics Market
  • TABLE 4 Product Launches And Product Expansions - Precision Diagnostics Market
  • TABLE 5 Acquisition and Mergers - Precision Diagnostics Market
  • TABLE 6 LAMEA Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 7 LAMEA Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 8 LAMEA Clinical Laboratories Market by Country, 2020 - 2023, USD Million
  • TABLE 9 LAMEA Clinical Laboratories Market by Country, 2024 - 2031, USD Million
  • TABLE 10 LAMEA Hospitals Market by Country, 2020 - 2023, USD Million
  • TABLE 11 LAMEA Hospitals Market by Country, 2024 - 2031, USD Million
  • TABLE 12 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 13 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 14 LAMEA Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 15 LAMEA Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 16 LAMEA Genetic Tests Market by Country, 2020 - 2023, USD Million
  • TABLE 17 LAMEA Genetic Tests Market by Country, 2024 - 2031, USD Million
  • TABLE 18 LAMEA Esoteric Tests Market by Country, 2020 - 2023, USD Million
  • TABLE 19 LAMEA Esoteric Tests Market by Country, 2024 - 2031, USD Million
  • TABLE 20 LAMEA Direct to Consumer Tests Market by Country, 2020 - 2023, USD Million
  • TABLE 21 LAMEA Direct to Consumer Tests Market by Country, 2024 - 2031, USD Million
  • TABLE 22 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 23 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 24 LAMEA Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 25 LAMEA Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 26 LAMEA Oncology Market by Country, 2020 - 2023, USD Million
  • TABLE 27 LAMEA Oncology Market by Country, 2024 - 2031, USD Million
  • TABLE 28 LAMEA Respiratory Diseases Market by Country, 2020 - 2023, USD Million
  • TABLE 29 LAMEA Respiratory Diseases Market by Country, 2024 - 2031, USD Million
  • TABLE 30 LAMEA CNS Disorders Market by Country, 2020 - 2023, USD Million
  • TABLE 31 LAMEA CNS Disorders Market by Country, 2024 - 2031, USD Million
  • TABLE 32 LAMEA Immunology Market by Country, 2020 - 2023, USD Million
  • TABLE 33 LAMEA Immunology Market by Country, 2024 - 2031, USD Million
  • TABLE 34 LAMEA Skin Diseases Market by Country, 2020 - 2023, USD Million
  • TABLE 35 LAMEA Skin Diseases Market by Country, 2024 - 2031, USD Million
  • TABLE 36 LAMEA Genetic Diseases Market by Country, 2020 - 2023, USD Million
  • TABLE 37 LAMEA Genetic Diseases Market by Country, 2024 - 2031, USD Million
  • TABLE 38 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 39 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 40 LAMEA Precision Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 41 LAMEA Precision Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 42 Brazil Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 43 Brazil Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 44 Brazil Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 45 Brazil Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 46 Brazil Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 47 Brazil Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 48 Brazil Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 49 Brazil Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 50 Argentina Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 51 Argentina Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 52 Argentina Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 53 Argentina Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 54 Argentina Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 55 Argentina Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 56 Argentina Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 57 Argentina Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 58 UAE Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 59 UAE Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 60 UAE Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 61 UAE Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 62 UAE Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 63 UAE Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 64 UAE Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 65 UAE Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 66 Saudi Arabia Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 67 Saudi Arabia Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 68 Saudi Arabia Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 69 Saudi Arabia Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 70 Saudi Arabia Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 71 Saudi Arabia Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 72 Saudi Arabia Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 73 Saudi Arabia Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 74 South Africa Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 75 South Africa Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 76 South Africa Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 77 South Africa Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 78 South Africa Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 79 South Africa Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 80 South Africa Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 81 South Africa Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 82 Nigeria Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 83 Nigeria Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 84 Nigeria Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 85 Nigeria Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 86 Nigeria Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 87 Nigeria Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 88 Nigeria Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 89 Nigeria Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 90 Rest of LAMEA Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 91 Rest of LAMEA Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 92 Rest of LAMEA Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 93 Rest of LAMEA Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 94 Rest of LAMEA Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 95 Rest of LAMEA Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 96 Rest of LAMEA Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 97 Rest of LAMEA Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 98 Key Information - Abbott Laboratories
  • TABLE 99 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 100 Key Information - Siemens Healthineers AG
  • TABLE 101 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 102 Key Information - Danaher Corporation
  • TABLE 103 key Information - Agilent Technologies, Inc.
  • TABLE 104 Key information - BioMerieux S.A.
  • TABLE 105 Key Information - Becton, Dickinson and Company
  • TABLE 106 Key Information - Qiagen N.V.
  • TABLE 107 Key Information - Hologic, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!